Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 2,352.00 | 1,847.16 | 1,225.91 | 1,526.26 |
Depreciation/ Depletion | 808.00 | 706.59 | 662.16 | 657.79 |
Non- Cash Items | 186.00 | 230.65 | 687.79 | 335.05 |
Changesin Working Capital | -80.00 | -357.44 | -772.87 | -513.75 |
Cashfrom Operating Activities | 3,266.00 | 2,426.96 | 1,802.99 | 2,005.35 |
Capital Expenditures | -433.00 | -573.94 | -202.57 | -335.15 |
Other Investing Cash Flow Items Total | 265.00 | -1,841.37 | 5.94 | -114.27 |
Cashfrom Investing Activities | -168.00 | -2,415.31 | -196.63 | -449.42 |
Financing Cash Flow Items | -371.00 | -303.02 | -257.72 | -356.05 |
Total Cash Dividends Paid | -1,015.00 | -863.04 | -676.89 | -338.45 |
Issuance( Retirement)of Debt Net | -1,393.00 | 1,243.42 | -846.44 | -956.29 |
Cashfrom Financing Activities | -2,779.00 | 77.36 | -1,781.05 | -1,650.79 |
Foreign Exchange Effects | 8.00 | 21.12 | 0.53 | 5.60 |
Net Changein Cash | 327.00 | 110.13 | -174.16 | -89.26 |
Cash Interest Paid | 371.00 | 303.02 | 257.72 | 356.05 |
Cash Taxes Paid | 498.00 | 398.07 | 421.02 | 175.50 |
Torrent Pharmaceuticals Dividend Torrent Pharmaceuticals Bonus Torrent Pharmaceuticals News Torrent Pharmaceuticals AGM Torrent Pharmaceuticals Rights Torrent Pharmaceuticals Splits Torrent Pharmaceuticals Board Meetings Torrent Pharmaceuticals Key Metrics Torrent Pharmaceuticals Shareholdings Torrent Pharmaceuticals Profit Loss Torrent Pharmaceuticals Balance Sheet Torrent Pharmaceuticals Q1 Results Torrent Pharmaceuticals Q2 Results Torrent Pharmaceuticals Q3 Results Torrent Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks